Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Lytgobi 4 mg film-coated tablets {equilateral_black_triangle}

Active Ingredient:
Futibatinib
Company:  
Taiho Pharma Europe Ltd See contact details
ATC code: 
L01EN04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Letters to HCPs
{arrow_left}
{arrow_right}

Important information for Healthcare Professionals

{pdf_link}

Lytgobi_DHPC_February 2025

{healthcare_pro_orange} For Healthcare Professionals

DHCP communication describing the interim supply of Lytgobi (4mg Futibatinib Tablets) with spanish Packages based on an MHRA exemption

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Taiho Pharma Europe Ltd
Company image
Address
Building 2, Croxley Business park, Watford, Hertfordshire, WD18 8YA, UK
Medical Information Direct Line
0800 04 89 461
Medical Information e-mail
[email protected]
Telephone
0800 04 89 461
Customer Care direct line
0800 04 89 461
Stock Availability
[email protected]
Stock Availability
+44 (0)1932 824 100
WWW
www.taihooncology.eu